Literature DB >> 6218115

[Antibiotic concentrations in the abdominal cavity as basis for antibacterial therapy of peritonitis: penetration of mezlocillin into the peritoneal exudate].

D H Wittmann, J Welter, H H Schassan.   

Abstract

The importance of the antibiotic concentration in peritoneal exudate is emphasized as a criterium for the possible success of antibiotic therapy of intra-abdominal infections. 5 g of mezlocillin were given i. v. over 15 min to ten patients with a mean age of 56 years. The serum concentrations, assayed microbiologically, were: 299.5 mg/l at the end of the infusion, 103.2 mg/l, 18.6 mg/l and 2.1 mg/l 60, 240 and 480 min after the end of the infusion, respectively. The serum half-life T1/2 beta, calculated from the beta phase, was 67 min. In the peritoneal fluid the peak concentration of Cp = 42.0 mg/l was achieved after 2.2 h. A quarter of this concentration was maintained in the peritoneal cavity for five to six hours. This concentration inhibited 74% of the 322 pathogens isolated from 123 intra-abdominal infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218115     DOI: 10.1007/bf01640673

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  The bacteriology of intra-abdominal infections.

Authors:  B Lorber; R M Swenson
Journal:  Surg Clin North Am       Date:  1975-12       Impact factor: 2.741

Review 2.  Bacteriology of the gut and its clinical implications.

Authors:  J S Clarke
Journal:  West J Med       Date:  1974-11

3.  Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics.

Authors:  D S Reeves; M J Bywater; H A Holt; J M Broughall
Journal:  Arzneimittelforschung       Date:  1979

4.  [Pharmacokinetics of propicillin in geriatric patients in comparison with younger adults].

Authors:  C Simon; V Malerczyk; U Müller; G Müller
Journal:  Dtsch Med Wochenschr       Date:  1972-12-29       Impact factor: 0.628

5.  [Septic diseases of the abdomen].

Authors:  H W Schreiber; H von Ackeren; M Rehner; K Schillig
Journal:  Chirurg       Date:  1971-08       Impact factor: 0.955

6.  Pharmacokinetics of mezlocillin in healthy volunteers.

Authors:  T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

7.  Kinetics of mezlocillin and carbenicillin.

Authors:  S J Pancoast; H C Neu
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

8.  [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].

Authors:  H Lode; U Niestrath; P Koeppe; H Langmaack
Journal:  Infection       Date:  1977       Impact factor: 3.553

9.  In vitro activity of mezlocillin and its related compounds against aerobic and anaerobic bacteria.

Authors:  H Thadepalli; I Roy; V T Bach; D Webb
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

10.  Empiric treatment with clindamycin and gentamicin of suspected sepsis due to anaerobic and aerobic bacteria.

Authors:  J G Bartlett; P V Miao; S L Gorbach
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.